Not on a phosphate binder, by DOPPS country and cross-section

  N Ptnts Total N Wgtd %
DOPPS Country DOPPS Cross-section 47 512 8.7%
AusNZ D2(2002)
D3(2006) 39 508 8.3%
D3(2007) 32 474 7.0%
D4(2010) 39 306 13.6%
Belgium D2(2002) 55 536 10.5%
D3(2006) 67 495 14.5%
D3(2007) 65 410 17.5%
D4(2010) 99 433 22.6%
Canada D2(2002) 31 587 4.9%
D3(2006) 37 540 7.5%
D3(2007) 33 443 9.3%
D4(2010) 34 305 12.0%
France D2(2002) 98 506 17.2%
D3(2006) 107 545 19.0%
D3(2007) 93 540 15.9%
D4(2010) 57 309 18.8%
Germany D2(2002) 105 559 18.4%
D3(2006) 90 570 14.6%
D3(2007) 97 619 14.5%
D4(2010) 111 542 20.6%
Italy D2(2002) 120 564 23.3%
D3(2006) 98 506 21.5%
D3(2007) 102 540 22.6%
D4(2010) 61 430 13.5%
Japan D2(2002) 355 1,763 19.1%
D3(2006) 270 1,820 14.7%
D3(2007) 328 1,839 18.0%
D4(2010) 282 1,691 16.7%
Spain D2(2002) 53 609 8.7%
D3(2006) 88 659 14.2%
D3(2007) 94 550 17.3%
D4(2010) 106 549 18.9%
Sweden D2(2002) 42 534 8.4%
D3(2006) 65 530 13.5%
D3(2007) 55 504 11.1%
D4(2010) 60 435 13.8%
UK D2(2002) 114 552 22.3%
D3(2006) 92 432 20.4%
D3(2007) 66 337 16.9%
D4(2010) 91 370 23.5%
US D2(2002) 311 2,230 13.9%
D3(2006) 236 1,791 11.8%
D3(2007) 167 1,308 13.0%
D4(2010) 421 3,112 15.0%

Medications reported as prescribed (not necessarily taken) in previous week, among all patients

Please see additional methodological information in the Data Sources and Methods section.